betaxolol has been researched along with Macular Edema in 2 studies
Macular Edema: Fluid accumulation in the outer layer of the MACULA LUTEA that results from intraocular or systemic insults. It may develop in a diffuse pattern where the macula appears thickened or it may acquire the characteristic petaloid appearance referred to as cystoid macular edema. Although macular edema may be associated with various underlying conditions, it is most commonly seen following intraocular surgery, venous occlusive disease, DIABETIC RETINOPATHY, and posterior segment inflammatory disease. (From Survey of Ophthalmology 2004; 49(5) 470-90)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Thirty-seven eyes (37 patients) with best-corrected visual acuity between 20/200 and 20/50 and macular edema that remained for 3 months after vitrectomy and removal of epiretinal membrane were prospectively, randomly assigned to receive betaxolol or placebo." | 9.10 | Randomized clinical trial of topical betaxolol for persistent macular edema after vitrectomy and epiretinal membrane removal. ( Kobayashi, H; Kobayashi, K; Okinami, S, 2003) |
| "Betaxolol is a new beta-adrenergic receptor blocker that preferentially blocks beta 1 receptors." | 5.27 | Aphakic cystoid macular edema secondary to betaxolol therapy. ( Hesse, RJ; Swan, JL, 1988) |
| "Thirty-seven eyes (37 patients) with best-corrected visual acuity between 20/200 and 20/50 and macular edema that remained for 3 months after vitrectomy and removal of epiretinal membrane were prospectively, randomly assigned to receive betaxolol or placebo." | 5.10 | Randomized clinical trial of topical betaxolol for persistent macular edema after vitrectomy and epiretinal membrane removal. ( Kobayashi, H; Kobayashi, K; Okinami, S, 2003) |
| "Betaxolol is a new beta-adrenergic receptor blocker that preferentially blocks beta 1 receptors." | 1.27 | Aphakic cystoid macular edema secondary to betaxolol therapy. ( Hesse, RJ; Swan, JL, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kobayashi, H | 1 |
| Kobayashi, K | 1 |
| Okinami, S | 1 |
| Hesse, RJ | 1 |
| Swan, JL | 1 |
1 trial available for betaxolol and Macular Edema
| Article | Year |
|---|---|
Randomized clinical trial of topical betaxolol for persistent macular edema after vitrectomy and epiretinal membrane removal.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Betaxolol; Double-Bli | 2003 |
1 other study available for betaxolol and Macular Edema
| Article | Year |
|---|---|
Aphakic cystoid macular edema secondary to betaxolol therapy.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Betaxolol; Cataract Extraction; Female; Glauco | 1988 |